Jpmorgan Chase & Co »

Ironwood Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Ironwood Pharmaceuticals (IRWD) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2012-06-30 $813k 59k 13.85
2010-12-31 $1.0M 98k 10.35

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Ironwood Pharmaceuticals

Sarissa Capital Management
Vanguard Group
LSV Asset Management
Credit Suisse
Dimensional Fund Advisors
Jacobs Levy Equity Management
Jupiter Asset Management
Point72 Asset Management
Jpmorgan Chase & Co
Man Group
Checkpoint Capital
Two Sigma Advisers
Charles Schwab Investment Management
Hotchkis and Wiley Capital Management
Goldman Sachs Group

View all funds holding Ironwood Pharmaceuticals